Clinical study of 20 cases of refractory Mycobacterium avium complex pulmonary disease treated with amikacin liposomal inhalation suspension

被引：0
|
作者：
Kaneko, Taichi [1 ]
Hagiwara, Eri [1 ]
Okuda, Ryo [1 ]
Ogura, Takashi [1 ]
机构：
[1] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO13-003
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [21] Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study
    Morimoto, Kozo
    Nonaka, Mizu
    Yamazaki, Yoshitaka
    Nakagawa, Taku
    Takasaki, Jin
    Tsuyuguchi, Kazunari
    Kitada, Seigo
    Jumadilova, Zhanna
    Yuen, Dayton W.
    Ciesielska, Monika
    Hasegawa, Naoki
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 284 - 290
  • [22] In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex
    Shulha, Jennifer
    MAYO CLINIC PROCEEDINGS, 2020, 95 (01) : 202 - 202
  • [23] A Retrospective Analysis to Assess the Effect of Targeted Clinical Interventions on the Discontinuation Rate of Amikacin Liposome Inhalation Suspension Therapy Among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease
    Hebble, S.
    Puc, M.
    Koerner, P.
    Barry, B.
    Faris, R.
    Vanscoy, G. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [24] Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use (vol 41, pg 405, 2021)
    Hoy, Sheridan M.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (06) : 591 - 591
  • [25] AN OPEN-LABEL EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Morimoto, Kozo
    Castellotti, Paola Francesca
    Yim, Jae-Joon
    Ruoss, Stephen
    van Ingen, Jakko
    Coulter, Christopher
    Mange, Kevin
    Nezamis, James
    Griffith, David
    CHEST, 2019, 156 (04) : 146A - 147A
  • [26] Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease: Effect of Baseline Amikacin and Clarithromycin Susceptibility on Culture Conversion
    Winthrop, K. L.
    Flume, P. A.
    Thomson, R.
    Brown-Elliott, B. A.
    Wallace, R. J., Jr.
    Griffith, D. E.
    Pennings, L. J.
    Coulter, C.
    Syrmis, M.
    Pandey, S.
    Yuen, D.
    Mange, K.
    van Ingen, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure
    Griffith, David E.
    Thomson, Rachel
    Flume, Patrick A.
    Aksamit, Timothy R.
    Field, Stephen K.
    Addrizzo-Harris, Doreen J.
    Morimoto, Kozo
    Hoefsloot, Wouter
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Wallace, Richard J., Jr.
    van Ingen, Jakko
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Winthrop, Kevin L.
    CHEST, 2021, 160 (03) : 831 - 842
  • [28] Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease (vol 79, pg 555, 2019)
    Shirley, Matt
    DRUGS, 2019, 79 (07) : 791 - 791
  • [29] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157
  • [30] Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
    Kim, Bo-Guen
    Kim, Hojoong
    Kwon, O. Jung
    Huh, Hee Jae
    Lee, Nam Yong
    Baek, Sun-Young
    Sohn, Insuk
    Jhun, Byung Woo
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 12
12345